Fund Holdings — BML Capital Management, LLC

Total Portfolio Value
$108.70M
Total Bought
$10.20M
Total Sold
$26.89M
Net Transaction
-$16.69M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ADVERUM BIOTECHNOLOGIES INC3,057,5263,057,52606,57413,85112.74%+7,277
ACLARIS THERAPEUTICS INC(ACRS)14,250,00014,250,000020,23527,07524.91%+6,840
PMV PHARMACEUTICALS INC(PMVP)5,000,0005,292,000+292,0005,3007,4096.82%+2,109
CONNECT BIOPHARMA HLDGS LTD(CNTB)01,267,500+1,267,50001,9141.76%+1,914
IMAGENEBIO INC(IMA)0182,509+182,50901,4871.37%+1,487
ORAMED PHARMACEUTICALS INC(ORMP)3,083,2533,167,231+83,9786,9378,3617.69%+1,424
ATHIRA PHARMA INC(LONA)0323,066+323,06601,3371.23%+1,337
ALUMIS INC1,210,4151,210,41503,6314,8304.44%+1,198
TARGET CORP(TGT)010,000+10,00008970.83%+897
LAVA THERAPEUTICS NV1,970,6101,970,61002,6013,0742.83%+473
ARVINAS INC(ARVN)050,000+50,00004260.39%+426
INSTIL BIO INC(TIL)534,899645,600+110,70111,14211,53010.61%+388
VISTAGEN THERAPEUTICS INC(VTGN)150,000150,00003005330.49%+233
MURAL ONCOLOGY PUB LTD CO057,500+57,50001190.11%+119
VERRICA PHARMACEUTICALS INC(VRCA)174,6510-174,651930—-93
KEZAR LIFE SCIENCES INC
COM NEW
635,183720,787+85,6042,9092,8112.59%-98
HILLEVAX INC91,9130-91,9131830—-183
ASTROTECH CORP220,410220,41001,2731,0800.99%-193
LISATA THERAPEUTICS INC(LSTA)209,814109,841-99,9736082880.26%-320
TURNSTONE BIOLOGICS CORP1,103,3860-1,103,3863960—-396
CORVUS PHARMACEUTICALS INC(CRVS)118,7660-118,7664750—-475
ATHIRA PHARMA INC3,230,6670-3,230,6679760—-976
CONNECT BIOPHARMA HLDGS LTD1,821,5580-1,821,5581,7850—-1,785
ELEVATION ONCOLOGY INC5,890,4340-5,890,4342,1620—-2,162
MILESTONE PHARMACEUTICALS IN(MIST)1,136,0910-1,136,0912,2040—-2,204
IKENA ONCOLOGY INC4,030,1020-4,030,1025,4000—-5,400
ATEA PHARMACEUTICALS INC(AVIR)7,609,8127,473,963-135,84927,39521,67419.94%-5,721
ESSA PHARMA INC4,221,5460-4,221,5467,1770—-7,177
THIRD HARMONIC BIO INC3,824,4173,824,417020,7670—-20,767
Page 1 of 1